Applied Therapeutics (APLT) Other Gross PP&E Adjustments (2023 - 2025)
Historic Other Gross PP&E Adjustments for Applied Therapeutics (APLT) over the last 3 years, with Q3 2025 value amounting to -$2.5 million.
- Applied Therapeutics' Other Gross PP&E Adjustments fell 2572.59% to -$2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.5 million, marking a year-over-year decrease of 2572.59%. This contributed to the annual value of -$2.8 million for FY2024, which is 52460.85% down from last year.
- Per Applied Therapeutics' latest filing, its Other Gross PP&E Adjustments stood at -$2.5 million for Q3 2025, which was down 2572.59% from -$2.6 million recorded in Q2 2025.
- Applied Therapeutics' 5-year Other Gross PP&E Adjustments high stood at -$206000.0 for Q2 2024, and its period low was -$2.8 million during Q4 2024.
- For the 3-year period, Applied Therapeutics' Other Gross PP&E Adjustments averaged around -$1.4 million, with its median value being -$743000.0 (2023).
- As far as peak fluctuations go, Applied Therapeutics' Other Gross PP&E Adjustments surged by 6719.75% in 2024, and later crashed by 115194.17% in 2025.
- Applied Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at -$447000.0 in 2023, then plummeted by 524.61% to -$2.8 million in 2024, then increased by 11.6% to -$2.5 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$2.5 million for Q3 2025, versus -$2.6 million for Q2 2025 and -$2.7 million for Q1 2025.